Trovagene (TROV) Tops Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. SPY
7. CVS
8. UNH
9. ZETA
10. DAL

Go back to Trovagene (TROV) Tops Q4 EPS by 1c

Trovagene, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results

March 12, 2015 4:05 PM EDT

SAN DIEGO, March 12, 2015 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today reported its financial results for the fourth quarter and full year ended December 31, 2014.

"We are releasing significant clinical data demonstrating that our molecular diagnostic platform is able to detect and monitor driver mutations in highly prevalent cancer types. Our assays provide critical information to oncologists to track the dynamic changes of a patient's tumor and their response to treatment at the genetic level," stated Antonius Schuh, Ph.D.,... More